MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Report Code: BIO115A

Publish Date: Nov 2012

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global microRNA research tools market was valued at nearly $295.1 million in 2011 and should reach nearly $338.3 million in 2012. Total market value is expected to reach $763 million in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 17.7%.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments during the last two years
  • Forecasts of the future situation and major drawbacks of the miRNA drug development model and possible solutions for these obstacles, especially in context of drug stability and delivery
  • Identification of the main markets for RNA therapeutics
  • Comprehensive company profiles of major players in the industry.

Report Scope

This report is a business tool that can help market players properly evaluate new commercial opportunities in the microRNA reagent, diagnostic and therapeutic submarkets.  The geographic scope of this study is global.  This market is generally complex and consists of a number of different segments, each of which is affected differently by scientific and technological developments.  This report identifies the main factors affecting each segment, and forecasts market growth, future trends, and product development in every major segment of this market.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology and industrial assay development and drug manufacturing. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets138Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: INTRODUCTION TO MICRORNA RESEARCH 14Free
Chapter- 4: RESEARCH TOOLS AND REAGENTS FOR MICRORNA RESEARCH AND PRODUCT DEVELOPMENT 24Free
Chapter- 5: MICRORNA DIAGNOSTICS AND BIOMARKER MARKET14Free
Chapter- 6: MICRORNA THERAPEUTICS IN RNA DRUG DISCOVERY MARKET42Free
Chapter- 7: IMPORTANCE OF BIOINFORMATICS TOOLS AND RECOURSES FOR MICRORNA RESEARCH AND PRODUCT DEVELOPMENT4Free
Chapter- 8: NEW TECHNOLOGIES, APPLICATIONS AND MARKETS IN MICRORNA RESEARCH AND PRODUCT DEVELOPMENT8Free
Chapter- 9: MARKET SUMMARY FOR MICRORNA RESEARCH AND PRODUCT DEVELOPMENT4Free
Chapter- 10: PROFILES OF SELECT COMPANIES9Free
Chapter- 11: LIST OF COMPANIES MENTIONED IN REPORT13Free

Related Reports

Top Ten Companies in DNA Sequencing

Published - Oct 2012 | Publisher - Stephen Weber | Code - BIO112A

Identifies the top 10 companies in DNA Sequencing Market. The goal of this document is to provide a more in-depth look at the top tier DNA sequencing companies as well as some of the second tier companies to look for in the near future

DNA Sequencing: Emerging Technologies and Applications

Published - Mar 2012 | Publisher - John Bergin | Code - BIO045D

The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.

RNAi Drug Delivery: Technologies and Global Markets

Published - Jan 2011 | Publisher - Usha Nagavarapu | Code - BIO076A

The global RNAi drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015 at a 5-year compound annual growth rate (CAGR) of 27.9%.

Recent Reports

RNA Sequencing: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO147B

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

European Life Science Tools and Reagents Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO262A

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

Global Multiomics Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO260A

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Electric Vehicles and Fuel Cell Vehicles: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - FCB040F

The global market for electric vehicles and fuel cell vehicles was valued at $655.9 billion in 2023. The market is expected to grow from $758.0 billion in 2024 to $1.8 trillion by 2029, at a compound annual growth rate (CAGR) of 18.6% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
Customize Report